top of page
Freenome
Freenome is a biotechnology company that integrates artificial intelligence with multi-omics data to develop non-invasive blood tests for early cancer detection.
• Uses machine learning to analyze genomic, proteomic, and epigenomic signals in blood
• Focused on developing early detection tests for colorectal cancer and other tumor types
• Supports precision oncology by identifying biomarkers and enhancing risk stratification
• Partners with healthcare providers and researchers for large-scale clinical validation
• Currently in advanced-stage clinical trials and not yet commercially available
No Reviews YetShare your thoughts.
Be the first to leave a review.
bottom of page